Brief: Sino Biopharmaceutical Declares Interim Dividend Of HK5 Cents Per Share
18/08/2025 09:37
Aug 18 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK: INTERIM DIVIDEND OF HK5 CENTS PER SHARE HY REVENUE RMB 17.57 BILLION HY PROFIT ATTRIBUTABLE RMB 3.09 BILLION Further company coverage: 1177.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up